Ray Dalio Edwards Lifesciences Corp Transaction History
Bridgewater Associates, LP
- $23.8 Billion
- Q3 2025
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 180,307 shares of EW stock, worth $15.6 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
180,307
Previous 444,924
59.47%
Holding current value
$15.6 Million
Previous $34.8 Million
59.7%
% of portfolio
0.06%
Previous 0.15%
Shares
31 transactions
Others Institutions Holding EW
# of Institutions
1,456Shares Held
468MCall Options Held
3.49MPut Options Held
4.09M-
Vanguard Group Inc Valley Forge, PA70.4MShares$6.07 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$4.4 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.6MShares$2.21 Billion0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY25.1MShares$2.16 Billion0.13% of portfolio
-
Wellington Management Group LLP Boston, MA20.8MShares$1.8 Billion0.3% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $53.4B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...